
Human urine based controls containing a large panel of drugs of abuse at various levels for monitoring immunoassay screening methods
Category Products
- Image
Liquichek Urine Toxicology Control, Levels S1O Low Opiate and S2O Low OpiateHuman urine controls containing drugs of abuse at concentrations below or above commonly used screen cutoff levels
- Image
Liquichek Urine Toxicology Control, Levels S1 and S2Human urine controls containing drugs of abuse at concentrations above or below immunoassay screen cutoff levels with 2000 ng/mL Opiate cutoff
- Image
Liquichek Urine Toxicology Control, Levels S1 Low Opiate and S2 Low OpiateHuman urine controls containing drugs of abuse at concentrations 20—25% above or below immunoassay screen cutoff levels with 300 ng/mL Opiate cutoff
- Image
Liquichek Urine Toxicology Control, Level S3Human urine control containing a large panel of drugs of abuse at elevated levels for immunoassay screening procedures with 300 ng/mL Opiate cutoff
- Image
Liquichek Urine Toxicology Control, Levels S1S and S2SHuman urine controls containing drugs of abuse at concentrations 20–25% above or below reduced SAMHSA screen cutoff levels
- Image
Liquichek Urine Toxicology Control, Levels S1E Low Opiate and S2E Low OpiateHuman urine controls containing a large panel of drugs of abuse at concentrations 20–25% above or below screen cutoff levels with 300 ng/mL Opiate cutoff
- Image
Liquichek Urine Toxicology Control, Levels S1E and S2EHuman urine controls containing a large panel of drugs of abuse at concentrations 20–25% above or below screen cutoff levels with 2000 ng/mL Opiate cutoff